Cannabis Goes Mainstream w/CVS and Walgreens. Non-Psychoactive CBD is TGOD’s Trojan Horse!
“CVS Pharmacy announced Wednesday (March 20) that it will begin selling hemp-derived CBD products in eight states. The national drug store chain will be marketing the topical cannabidiol products, such as creams, sprays and roll-ons, as “an alternative source of relief,” CVS said in a statement to NBC News. CVS will also be partnering with a company to test and verify the quality of the CBD topicals sold in its drug stores.
“We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options,” said CVS Health Spokesperson, Mike DeAngelis.
The items will be sold in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee.
CBD, or cannabidiol, comes from the hemp plant, a close relative to another member of the cannabis family, marijuana. Both plants contain abundant types of cannabinoids, but marijuana is high in the psychoactive chemical THC, while hemp is rich in CBD, the non-psychoactive component of cannabis that has generated quite a buzz for its potential medicinal benefits.
CVS has at least 9,800 stores nationwide and will soon roll out the CBD products in over 800 stores in the eight states. The health care chain says that effectiveness claims will vary from product-to-product, but that the company does not plan to market any of the items as a ‘cure-all’ product.
“We’re going to walk slowly, but this is something we think our customers will be looking for,” CVS Health CEO Larry Merlo said in an interview Wednesday with CNBC’s Jim Cramer”. — NBC
“CVS Health Corp. this week will begin selling products infused with the trendy, non-intoxicating hemp component at more than 800 of its stores as part of a distribution deal with marijuana company Curaleaf Holdings Inc., Curaleaf said Wednesday.
Curaleaf announced the agreement during an earnings conference call on Wednesday. The company’s CBD products will be available in about 800 stores to start, Curaleaf said on the call, and hopes to expand to more”. — Bloomberg
The day of the partnership announcement, shares of Curaleaf Holdings (CURA) soared 32% to an ATH of $12.06 CAD. The shares continued to make gains in the days that followed.
Just one week after CVS made their CBD announcement, Walgreens said they, “will sell CBD creams, patches and sprays in nearly 1,500 stores in select states, the company told CNBC on Wednesday (March 27th).
The drugstore chain will sell the cannabis-based products in Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana. Walgreens declined to specify which brands it would carry.
“This product offering is in line with our efforts to provide a wider range of accessible health and wellbeing products and services to best meet the needs and preferences of our customers,” Walgreens spokesman Brian Faith said in an email to CNBC”.- CNBC
“Cannabidiol (CBD) is a naturally occurring compound found in the resinous flower of cannabis, a plant with a rich history as a medicine going back thousands of years. Today the therapeutic properties of CBD are being tested and confirmed by scientists and doctors around the world. A safe, non-addictive substance, CBD is one of more than a hundred “phytocannabinoids,” which are unique to cannabis and endow the plant with its robust therapeutic profile.
CBD is closely related to another important medicinally active phytocannabinoid: tetrahydrocannabinol (THC), the compound that causes the high that cannabis is famous for. These are the two components of cannabis that have been most studied by scientists.
Both CBD and THC have significant therapeutic attributes. But unlike THC, CBD does not make a person feel “stoned” or intoxicated. That’s because CBD and THC act in different ways on different receptors in the brain and body.
CBD can actually lessen or neutralize the psychoactive effects of THC, depending on how much of each compound is consumed. Many people want the health benefits of cannabis without the high — or with less of a high.
The fact that CBD is therapeutically potent as well as non-intoxicating, and easy to take as a CBD oil, makes it an appealing treatment option for those who are cautious about trying cannabis for the first time”. — Projectcbd
“What Are the Medical Benefits of CBD?
Research studies indicate that CBD may be useful in helping with:
- Pain (neuropathic, chronic, cancer-related, etc.)
- Multiple Sclerosis (MS)
- Amyotrophic Lateral Sclerosis (ALS)
- Broken Bones
- Mad Cow Disease
- Bacterial Infections
- Rheumatoid Arthritis
- Substance Abuse/Withdrawal
- Heart Disease
- Irritable Bowel Syndrome (IBS)”
The Green Organic Dutchman CEO says CBD is its “Trojan Horse” into the European market. TGOD announced a definitive agreement to acquire 100% of European cannabis company Hempoland for $35 Million on August 21, 2018.
“HemPoland is a leading European manufacturer and marketer of premium organic CBD oils led by founder and CEO, Maciej Kowalski, one of Europe’s most widely recognized CBD experts. This strategic acquisition provides access to HemPoland’s vast distribution network, premium Cannabigold brand, state-of-the-art hemp oil extraction technologies, and provides a strategic pathway into the European market for TGOD’s medical & recreational products and licensing deals.
Founded in 2014, HemPoland was the first company in Poland to obtain a state license allowing the company to grow hemp and manufacture CBD oil products. HemPoland’s management is comprised of experts in cultivation, oil extraction, and marketing of high-quality organic CBD oil. The company is vertically integrated, with over 1,250 acres of cultivation leveraging third parties, multiple commercial scale extraction units, local distributors in Poland, Austria, Netherlands, Germany, United Kingdom, Italy, Switzerland, Portugal, Ireland, Czech Republic, Slovenia, Lithuania, and Estonia, and product sales in over 700 locations. With a robust ecommerce platform, diverse wholesale model, and over 60 employees, HemPoland has proven the ability to execute by rapidly scaling across the European Union in a short timeframe. In 2017, the company produced over 32,000 kgs of organic dried flower and 310 kgs of organic CBD oils”. — Newcannabisventures
“Opioid addiction has become a rising epidemic throughout the world, particularly gaining attention in the United States and Canada as a situation of national crisis. Opioid addiction typically develops later in life, but in some instances, it can even in newborns and young children (in these situations the “addiction” is primarily a cause of the mother using prescription drugs during pregnancy).
Opioids are generally classed into two categories: non-prescription and prescription. The addiction epidemic involves the use of both categories in large numbers, but recently it seems the trend is pointing towards a greater abuse of prescription medications.
In light of recent numbers and estimates regarding opioid dependency and abuse, researchers have begun searching for safer methods of treatment that may be able to assist those who are going through abuse or addiction, and need to get clean.
The world of CBD has become an especially intriguing possibility, as researchers have begun collecting data as to its ability to help steer addicts from dependency and onto a cleaner, healthier, more natural path.
Although further research certainly needs to be conducted over the coming years, there are publications that have already provided rather promising results.
In fact, one study in particular has suggested that CBD helps to block the opioid reward mechanism; in other words, when given to someone who is addicted to opioid medication, it appears that CBD may be able to help the patient become independent from the drug’s addictive properties — which could lead them down a path to full recovery”. — Marijuanabreak
Whether you agree with cannabis use or not, the fact is the plant is becoming used for much more than just hanging out and getting high (of course that reason still exists). The breakthrough of cannabis into medicine, pharmaceuticals, etc. will disrupt the industries profoundly.
“Once an illegal and somewhat niche product, legal cannabis is now a fast-growing global industry. And it’s proving to be disruptive, impacting everything from beverage production to home construction.
Recent analyst reports estimate that the global legal marijuana industry will reach more than $20B by 2025.
Medical marijuana is already legal in more than half the United States, and eight states (plus Washington DC) have legalized marijuana for recreational use. It’s soon to be fully legal in all of Canada.
There’s also been a large uptick in public and private investment in new, safer forms of ingestible marijuana, while cannabis startups — focused on everything from therapeutics applications to cultivation techniques — are also cropping up. Financing to cannabis companies more than doubled in 2017". — CBinsights
Invest in the future of Cannabis! Go TGOD!
If you enjoyed reading this and think others should too, ☞ Please tap or click 👏(left sidebar or bottom of page). It’ll give me incentive to keep writing andMedium’s algorithms promote blogs with claps to other readers.